123 related articles for article (PubMed ID: 16505160)
1. Localization of the kappa opioid receptor in lipid rafts.
Xu W; Yoon SI; Huang P; Wang Y; Chen C; Chong PL; Liu-Chen LY
J Pharmacol Exp Ther; 2006 Jun; 317(3):1295-306. PubMed ID: 16505160
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells.
Huang P; Xu W; Yoon SI; Chen C; Chong PL; Liu-Chen LY
Biochem Pharmacol; 2007 Feb; 73(4):534-49. PubMed ID: 17141202
[TBL] [Abstract][Full Text] [Related]
3. The alpha1a-adrenergic receptor occupies membrane rafts with its G protein effectors but internalizes via clathrin-coated pits.
Morris DP; Lei B; Wu YX; Michelotti GA; Schwinn DA
J Biol Chem; 2008 Feb; 283(5):2973-85. PubMed ID: 18048357
[TBL] [Abstract][Full Text] [Related]
4. Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model.
Horváth Á; Steib A; Nehr-Majoros A; Kántás B; Király Á; Racskó M; Tóth BI; Szánti-Pintér E; Kudová E; Skoda-Földes R; Helyes Z; Szőke É
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731855
[TBL] [Abstract][Full Text] [Related]
5. Differential requirement of lipid rafts for FcγRIIA mediated effector activities.
Vieth JA; Kim MK; Pan XQ; Schreiber AD; Worth RG
Cell Immunol; 2010; 265(2):111-9. PubMed ID: 20728077
[TBL] [Abstract][Full Text] [Related]
6. Structural and Functional Determinants of AC8 Trafficking, Targeting and Responsiveness in Lipid Raft Microdomains.
Tabbasum VG; Cooper DMF
J Membr Biol; 2019 Jun; 252(2-3):159-172. PubMed ID: 30746562
[TBL] [Abstract][Full Text] [Related]
7. Initial steps of Shigella infection depend on the cholesterol/sphingolipid raft-mediated CD44-IpaB interaction.
Lafont F; Tran Van Nhieu G; Hanada K; Sansonetti P; van der Goot FG
EMBO J; 2002 Sep; 21(17):4449-57. PubMed ID: 12198147
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein and 'lipid rafts': some ambiguous mutual relationships (floating on them, building them or meeting them by chance?).
Orlowski S; Martin S; Escargueil A
Cell Mol Life Sci; 2006 May; 63(9):1038-59. PubMed ID: 16721513
[TBL] [Abstract][Full Text] [Related]
9. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers.
Westover EJ; Covey DF; Brockman HL; Brown RE; Pike LJ
J Biol Chem; 2003 Dec; 278(51):51125-33. PubMed ID: 14530278
[TBL] [Abstract][Full Text] [Related]
10. Association of FcgammaRIIa (CD32a) with lipid rafts regulates ligand binding activity.
Bournazos S; Hart SP; Chamberlain LH; Glennie MJ; Dransfield I
J Immunol; 2009 Jun; 182(12):8026-36. PubMed ID: 19494328
[TBL] [Abstract][Full Text] [Related]
11. Membrane lipid rafts and neurobiology: age-related changes in membrane lipids and loss of neuronal function.
Egawa J; Pearn ML; Lemkuil BP; Patel PM; Head BP
J Physiol; 2016 Aug; 594(16):4565-79. PubMed ID: 26332795
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelinases D From
Lopes PH; van den Berg CW; Tambourgi DV
Front Pharmacol; 2020; 11():636. PubMed ID: 32477123
[No Abstract] [Full Text] [Related]
13. Lipid profile dysregulation in opium users based on Fasa PERSIAN cohort study results.
Kazemi M; Bazyar M; Naghizadeh MM; Dehghan A; Rahimabadi MS; Chijan MR; Bijani M; Zahmatkeshan M; Ghaemi A; Samimi N; Homayounfar R; Farjam M
Sci Rep; 2021 Jun; 11(1):12058. PubMed ID: 34103610
[TBL] [Abstract][Full Text] [Related]
14. Kappa-opioid receptor-dependent changes in dopamine and anxiety-like or approach-avoidance behavior occur differentially across the nucleus accumbens shell rostro-caudal axis.
Pirino BE; Spodnick MB; Gargiulo AT; Curtis GR; Barson JR; Karkhanis AN
Neuropharmacology; 2020 Dec; 181():108341. PubMed ID: 33011200
[TBL] [Abstract][Full Text] [Related]
15. Location and Cell-Type-Specific Bias of Metabotropic Glutamate Receptor, mGlu
Jong YI; Harmon SK; O'Malley KL
ACS Chem Neurosci; 2019 Nov; 10(11):4558-4570. PubMed ID: 31609579
[TBL] [Abstract][Full Text] [Related]
16. Dynamic lateral organization of opioid receptors (kappa, mu
Rogacki MK; Golfetto O; Tobin SJ; Li T; Biswas S; Jorand R; Zhang H; Radoi V; Ming Y; Svenningsson P; Ganjali D; Wakefield DL; Sideris A; Small AR; Terenius L; Jovanović-Talisman T; Vukojević V
Traffic; 2018 May; 19(9):690-709. PubMed ID: 29808515
[TBL] [Abstract][Full Text] [Related]
17. Determination of μ-, δ- and κ-opioid receptors in forebrain cortex of rats exposed to morphine for 10 days: Comparison with animals after 20 days of morphine withdrawal.
Ujcikova H; Hlouskova M; Cechova K; Stolarova K; Roubalova L; Svoboda P
PLoS One; 2017; 12(10):e0186797. PubMed ID: 29053731
[TBL] [Abstract][Full Text] [Related]
18. Presence of Androgen Receptor Variant in Neuronal Lipid Rafts.
Garza-Contreras J; Duong P; Snyder BD; Schreihofer DA; Cunningham RL
eNeuro; 2017; 4(4):. PubMed ID: 28856243
[TBL] [Abstract][Full Text] [Related]
19. Allostery at opioid receptors: modulation with small molecule ligands.
Livingston KE; Traynor JR
Br J Pharmacol; 2018 Jul; 175(14):2846-2856. PubMed ID: 28419415
[TBL] [Abstract][Full Text] [Related]
20. Membrane cholesterol access into a G-protein-coupled receptor.
Guixà-González R; Albasanz JL; Rodriguez-Espigares I; Pastor M; Sanz F; Martí-Solano M; Manna M; Martinez-Seara H; Hildebrand PW; Martín M; Selent J
Nat Commun; 2017 Feb; 8():14505. PubMed ID: 28220900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]